The impact of antimicrobial stewardship on reserve antibiotic use and procuring cost

IF 0.5 Q4 EDUCATION, SCIENTIFIC DISCIPLINES

Pharmacy Education Pub Date : 2023-10-10 DOI:10.46542/pe.2023.234.149153

Mariyatul Qibtiyah, Joni Wahyuhadi, Junaidi Khotib

{"title":"The impact of antimicrobial stewardship on reserve antibiotic use and procuring cost","authors":"Mariyatul Qibtiyah, Joni Wahyuhadi, Junaidi Khotib","doi":"10.46542/pe.2023.234.149153","DOIUrl":null,"url":null,"abstract":"Background: Antimicrobial Stewardship (AMS) is an intervention designed to optimise the appropriate use of antibiotics is expected to reduce selective pressure on microbes, control antimicrobial resistance, improve patient clinical outcomes, and cost reduction. Objective: The aim of this study is to analyse the impact of antimicrobial stewardship on \"reserve\" antibiotics use and procuring cost of antibiotics in hospitals. Method: The study was conducted at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. A retrospective observational design study to analyse trends of \"reserve\" antibiotics use and procuring cost before AMS implementation (January 2018-December 2019) and after AMS implementation (January 2020-December 2021). Results: The total meropenem consumption before AMS intervention in January 2018-December 2019 was 9950 DDD, and after AMS intervention in January 2020-December 2021 was 4639 DDD, showing a decrease of 53 %. Procuring Meropenem cost in 2018-2019 was Indonesian Rupiah (IDR) 1.490 billion and IDR 309 million between 2020 to 2021. Cost reduction positively impacts saving procurement costs in hospitals of IDR 1.18 billion (79%). Conclusion: The impact antimicrobial stewardship programs can reduce reserve antibiotic use with meropenem indicator and have a sustainable economic impact, saving the cost of procuring antibiotics in hospitals.","PeriodicalId":19944,"journal":{"name":"Pharmacy Education","volume":"227 1","pages":"0"},"PeriodicalIF":0.5000,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacy Education","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46542/pe.2023.234.149153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"EDUCATION, SCIENTIFIC DISCIPLINES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Antimicrobial Stewardship (AMS) is an intervention designed to optimise the appropriate use of antibiotics is expected to reduce selective pressure on microbes, control antimicrobial resistance, improve patient clinical outcomes, and cost reduction. Objective: The aim of this study is to analyse the impact of antimicrobial stewardship on "reserve" antibiotics use and procuring cost of antibiotics in hospitals. Method: The study was conducted at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. A retrospective observational design study to analyse trends of "reserve" antibiotics use and procuring cost before AMS implementation (January 2018-December 2019) and after AMS implementation (January 2020-December 2021). Results: The total meropenem consumption before AMS intervention in January 2018-December 2019 was 9950 DDD, and after AMS intervention in January 2020-December 2021 was 4639 DDD, showing a decrease of 53 %. Procuring Meropenem cost in 2018-2019 was Indonesian Rupiah (IDR) 1.490 billion and IDR 309 million between 2020 to 2021. Cost reduction positively impacts saving procurement costs in hospitals of IDR 1.18 billion (79%). Conclusion: The impact antimicrobial stewardship programs can reduce reserve antibiotic use with meropenem indicator and have a sustainable economic impact, saving the cost of procuring antibiotics in hospitals.

查看原文本刊更多论文

抗菌药物管理对储备抗生素使用和采购成本的影响

背景:抗菌药物管理(AMS)是一项旨在优化抗生素合理使用的干预措施，有望减少微生物的选择压力，控制抗菌药物耐药性，改善患者临床结果，并降低成本。目的:分析抗菌药物管理对医院“储备”抗菌药物使用及抗菌药物采购成本的影响。方法:本研究在印度尼西亚泗水Soetomo博士综合学术医院进行。一项回顾性观察性设计研究，分析辅助医疗服务实施前(2018年1月- 2019年12月)和实施后(2020年1月- 2021年12月)“储备”抗生素使用和采购成本的趋势。结果:2018年1月- 2019年12月，AMS干预前美罗培南总用量为9950 DDD, 2020年1月- 2021年12月，AMS干预后美罗培南总用量为4639 DDD，减少53%。2018-2019年采购美罗培南的成本为14.9亿印尼盾，2020 - 2021年为3.09亿印尼盾。成本降低对医院采购成本节约产生了积极影响，节省了11.8亿印尼盾(79%)。结论:影响抗菌药物管理项目可减少美罗培南指标下的储备抗生素使用，并产生可持续的经济影响，节约医院抗菌药物采购成本。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacy Education EDUCATION, SCIENTIFIC DISCIPLINES-

CiteScore

0.80

自引率

20.00%

发文量

174

期刊介绍： Pharmacy Education journal provides a research, development and evaluation forum for communication between academic teachers, researchers and practitioners in professional and pharmacy education, with an emphasis on new and established teaching and learning methods, new curriculum and syllabus directions, educational outcomes, guidance on structuring courses and assessing achievement, and workforce development. It is a peer-reviewed online open access platform for the dissemination of new ideas in professional pharmacy education and workforce development. Pharmacy Education supports Open Access (OA): free, unrestricted online access to research outputs. Readers are able to access the Journal and individual published articles for free - there are no subscription fees or ''pay per view'' charges. Authors wishing to publish their work in Pharmacy Education do so without incurring any financial costs.